Herman Verrelst
InvestorFounding Partner & Senior Advisor at Heran Partners
Leuven, Flemish Region, Belgium
Find your path to Herman
296 people in our graph share verified history with Herman — schools, employers, funds. One of them is your warm intro.
About
Herman Verrelst is a serial entrepreneur with over 25 years in high-tech companies. He founded and exited several University of Leuven spin-offs, including Cartagenia, which was acquired by Agilent, after which he led Agilent's Genomics & Clinical Applications division in California. He later served as CEO of Biocartis, a molecular diagnostics company focused on personalized medicine.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Experience
- GynaiaExecutive Chairmancurrent2025 — present
- Aspect AnalyticsChairpersoncurrent2025 — present
- Aspect AnalyticsBoard Member2025
- Aspect AnalyticsExecutive Chair2023 — 2024
- nuclivisionBoard Membercurrent2025 — present
- HERAN PartnersFounding Partnercurrent2020 — present
- BioviaBoard Membercurrent2025 — present
- BiocartisChairman2023 — 2025
- BiocartisExecutive Chairman2023
- BiocartisChief Executive Officer2017 — 2023
- MedviaChairman of the Board2021 — 2025
- Ellison Institute of Technology OxfordChief Business Officer2024Oxford, England, United Kingdom
- icoMetrixBoard Member2013 — 2024
- flanders.bioBoard Member2018 — 2022
- FOx BiosystemsBoard Member2019 — 2020
- UgenTecBoard Member2015 — 2018
- Agilent TechnologiesVP and General Manager - Genomics and Clinical Application division2015 — 2017Santa Clara, California
- Agilent TechnologiesGeneral Manager - Clinical Applications Division2015
- CartageniaChief Executive Officer2011 — 2015
- CartageniaManaging Director2008 — 2011
- ParticipatieMaatschappij VlaanderenMember Investment Committee - VINNOF2010 — 2015
- EpsynomicsManaging Director2009 — 2010
- Nobel BiocareBusiness Unit Manager2008 — 2009
- Medicim NVManaging Director2007 — 2009
- Norkom TechnologiesDirector European Operations2004 — 2007
- DATA4sCEO2000 — 2004
- Katholieke Universiteit LeuvenPhD Researcher1996 — 1999
Skills & more
+5 more
Molecular BiologyLife SciencesAnalysisManagementStrategyFrom Herman's professional profile.
Colleagues at Heran Partners
Frequently asked questions
- Who is Herman Verrelst?
- Herman Verrelst is a serial entrepreneur with over 25 years in high-tech companies. He founded and exited several University of Leuven spin-offs, including Cartagenia, which was acquired by Agilent, after which he led Agilent's Genomics & Clinical Applications division in California. He later served as CEO of Biocartis, a molecular diagnostics company focused on personalized medicine.
- Where does Herman Verrelst work?
- Herman Verrelst is Founding Partner & Senior Advisor at Heran Partners.
- What does Herman Verrelst invest in?
- Herman Verrelst invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- Where did Herman Verrelst go to school?
- Herman Verrelst studied at KU Leuven (Master in Engineering); Stanford University Graduate School of Business (Leading Change and Organizational Renewal).
Founder mafias
Stanford University Graduate School of Business mafia748
Also came through, then founded or led a company.
+ 741 more
KU Leuven mafia73
Also came through, then founded or led a company.
+ 66 more
Same school
Also attended KU Leuven316
+ 310 more
Also attended Stanford University Graduate School of Business2,000
+ 1,994 more
Shared employers
Also worked at Biovia4
Also worked at FOx Biosystems1
Also worked at ParticipatieMaatschappij Vlaanderen13
+ 7 more
Also worked at Nobel Biocare8
+ 2 more


























































